---
title: "Aktis Oncology’s Q3 Net Loss Nearly Doubles to $29.9 Million"
url: https://thecoingazette.com/aktis-oncologys-q3-net-loss-nearly-doubles-to-29-9-million/
date: 2026-11-12
modified: 2026-11-12
lang: en
author: "Coin Gazette Editorial"
description: "Research and development expenses rose to $32.1 million as the company began a third Phase 1b trial and expects its cash to fund operations into 2029."
categories:
  - "Crypto News"
tags:
  - "crypto"
  - "cryptocurrencies"
  - "Defi"
  - "Market Trends"
  - "News"
word_count: 26
---

# Aktis Oncology’s Q3 Net Loss Nearly Doubles to $29.9 Million

Research and development expenses rose to $32.1 million as the company began a third Phase 1b trial and expects its cash to fund operations into 2029.